Skip to main content
Equibles
HIMS logo

HIMS · Hims & Hers Health, Inc. · Earnings Call Transcripts & Audio

Track HIMS — free

Use HIMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HIMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.79 +1.09 (+3.80%) At close · Sep 30
S&P 400 member Russell 2000 member Rebalance outlook locked
Customer concentration — top customer 10% of receivables

One customer — 10% of receivables (December 31, 2025)

“As of December 31, 2025, one customer or partner individually represented more than 10% of accounts receivable.”

4 customers — 10% of receivables (December 31, 2024)

“As of December 31, 2024, four customers or partners individually represented more than 10% of accounts receivable.”
View the 10-K filed Feb 23, 2026
Market Cap
$6.86B
Shares
233.31M
Volume · Sep 30 14.52M Avg daily vol (3M) 12.63M

Hims & Hers Health, Inc. Earnings Call Transcripts

Quarterly earnings calls for Hims & Hers Health, Inc. (HIMS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲95.3% $144.84M −$18.84M '22 Q3 22-11-07 ▲97.4% $167.20M −$10.91M '22 Q4 23-02-27 ▲88.3% $190.77M −$10.07M '23 Q1 23-05-08 ▲83.1% $207.91M −$7.16M '23 Q2 23-08-07 ▲56.5% $226.70M −$7.57M '23 Q3 23-11-06 ▲47.5% $246.62M $1.25M '23 Q4 24-02-26 ▲45.8% $278.17M $11.13M '24 Q1 24-05-06 ▲51.8% $315.65M $13.30M '24 Q2 24-08-05 ▲77.1% $401.56M $75.59M '24 Q3 24-11-04 ▲95.1% $481.14M $26.02M '24 Q4 25-02-24 ▲110.7% $586.01M $49.48M '25 Q1 25-05-05 ▲72.6% $544.83M $42.51M '25 Q2 25-08-04 ▲49.2% $598.98M $15.77M '25 Q3 25-11-03 ▲28.4% $617.82M $20.60M '25 Q4 26-02-23 ▲3.8% $608.10M −$92.11M '26 Q1 26-05-11 LATEST ▲38.2% $753.21M −$86.29M '26 Q2 26-08-10
Earnings call
FY26 · Q2
2026-08-10
Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript
Confident tone AI and technology platform International expansion / Eucalyptus Weight loss category (Hers)
Revenue
$753.21M
▲ 38.2% YoY
Diluted EPS
$-0.37
▼ 317.6% YoY
Gross margin
63.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
Hims & Hers Health, Inc. (HIMS) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-11
Hims & Hers Health, Inc. (HIMS) Q1 2026 Earnings Call Transcript
Confident tone Data, technology and platform network effects Capital allocation discipline / free cash flow Weight loss / GLP-1 strategy
Revenue
$608.10M
▲ 3.8% YoY
Diluted EPS
$-0.40
▼ 300% YoY
Gross margin
65.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-23
Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript
Confident tone GLP-1 and weight loss offering International expansion and M&A Platform diversification and new specialties
Revenue
$617.82M*
▲ 28.4% YoY
Gross margin
71.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Hims & Hers Health, Inc. (HIMS) Q3 2025 Earnings Call Transcript
Confident tone Personalized care and platform expansion Weight loss / GLP-1 Financial outlook and 2030 targets
Revenue
$598.98M
▲ 49.2% YoY
Diluted EPS
$0.06
▼ 81.2% YoY
Gross margin
73.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Hims & Hers Health, Inc. (HIMS) Q2 2025 Earnings Call Transcript
Confident tone Weight loss / GLP-1 retention results Capital allocation and marketing payback Lab testing / longevity vertical integration
Revenue
$544.83M
▲ 72.6% YoY
Diluted EPS
$0.17
▲ 183.3% YoY
Gross margin
76.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Hims & Hers Health, Inc. (HIMS) Q1 2025 Earnings Call Transcript
Confident tone Weight loss / GLP-1 offerings Cash-pay model vs. insurance Long-term growth targets (2030)
Revenue
$586.01M
▲ 110.7% YoY
Diluted EPS
$0.20
▲ 300% YoY
Gross margin
73.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-24
Hims & Hers Health, Inc. (HIMS) Q4 2024 Earnings Call Transcript
Confident tone GLP-1 / Weight Loss Business Women's Health (Hers Brand) Whole Body Lab Testing Acquisition
Revenue
$481.14M*
▲ 95.1% YoY
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript
Confident tone Personalized solutions and platform capabilities GLP-1 / Weight loss business Provider experience and adherence / retention
Revenue
$401.56M
▲ 77.1% YoY
Diluted EPS
$0.32
Gross margin
79.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Hims & Hers Health, Inc. (HIMS) Q2 2024 Earnings Call Transcript
Confident tone Weight management / GLP-1 launch Personalized solutions & platform expansion Subscriber growth and financial performance
Revenue
$315.65M
▲ 51.8% YoY
Diluted EPS
$0.06
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Hims & Hers Health, Inc. (HIMS) Q1 2024 Earnings Call Transcript
Confident tone Personalized solutions platform Financial performance and guidance Weight loss / GLP-1
Revenue
$278.17M
▲ 45.8% YoY
Diluted EPS
$0.05
Gross margin
82.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
Hims & Hers Health, Inc. (HIMS) Q4 2023 Earnings Call Transcript
Confident tone Revenue and subscriber growth Affiliated pharmacies and cost Core specialties expansion
Revenue
$246.62M*
▲ 47.5% YoY
Gross margin
82.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Hims & Hers Health, Inc. (HIMS) Q3 2023 Earnings Call Transcript
Revenue
$226.70M
▲ 56.5% YoY
Diluted EPS
$-0.04
Gross margin
82.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Hims & Hers Health, Inc. (HIMS) Q2 2023 Earnings Call Transcript
Revenue
$207.91M
▲ 83.1% YoY
Diluted EPS
$-0.03
Gross margin
81.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Hims & Hers Health, Inc. (HIMS) Q1 2023 Earnings Call Transcript
Revenue
$190.77M
▲ 88.3% YoY
Diluted EPS
$-0.05
Gross margin
80.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-27
Hims & Hers Health, Inc. (HIMS) Q4 2022 Earnings Call Transcript
Revenue
$167.20M*
▲ 97.4% YoY
Gross margin
79.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Hims & Hers Health, Inc. (HIMS) Q3 2022 Earnings Call Transcript
Revenue
$144.84M
▲ 95.3% YoY
Diluted EPS
$-0.09
Gross margin
79.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Hims & Hers Health, Inc. (HIMS) Q2 2022 Earnings Call Transcript
Revenue
$113.56M
▲ 87.1% YoY
Diluted EPS
$-0.10
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Hims & Hers Health, Inc. (HIMS) Q1 2022 Earnings Call Transcript
Revenue
$101.31M
▲ 93.7% YoY
Diluted EPS
$-0.08
Gross margin
73.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Hims & Hers Health, Inc. (HIMS) Q4 2021 Earnings Call Transcript
Revenue
$84.70M*
▲ 104.3% YoY
Gross margin
73.3%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Hims & Hers Health, Inc. (HIMS) Q3 2021 Earnings Call Transcript
Revenue
$74.17M
▲ 79.5% YoY
Diluted EPS
$-0.08
Gross margin
74.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
Hims & Hers Health, Inc. (HIMS) Q2 2021 Earnings Call Transcript
Revenue
$60.69M
▲ 69% YoY
Diluted EPS
$-0.05
Gross margin
77.9%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-18
Hims & Hers Health, Inc. (HIMS) Q1 2021 Earnings Call Transcript
Revenue
$52.31M
▲ 74% YoY
Diluted EPS
$-0.34
Gross margin
76.9%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-18
Hims & Hers Health, Inc. (HIMS) Q4 2020 Earnings Call
Revenue
$41.47M*
Gross margin
76.9%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 earnings calls
Key facts CIK 1773751 CUSIP 433000106 13F (30d) 22 filings 13 filers Visit website Investor relations